Brook.ai, a Seattle-area health technology startup that uses AI to help clinical teams to deliver remote care, raised a $28 million Series B round led by UMass Memorial Health and Morningside.
Founded in 2015, Brooks’ platform combines data analytics, automated nudges, and support from clinicians and health coaches to help patients manage chronic conditions from home.
The company says its approach can cut hospital readmissions — such as for congestive heart failure — and improve metrics like hypertension control. It promotes its platform as a turnkey system that can be deployed in 30 days.
Brook reported 204% patient growth over the past year, and an 82% retention rate.
Brook began as a diabetes management startup, combining data from devices and coaching to support glucose control. It later broadened its scope, layering in hypertension, metabolic health, and general chronic disease care.
The company is expanding amid reimbursement and policy shifts that increasingly favor remote and home-based care. But the sector faces hurdles, including complex data integration, long sales cycles, and regulatory burdens.
The broader remote healthcare market is projected to expand from roughly $69 billion in 2024 to over $219 billion by 2030, according to Grand View Research.
Brook co-founder and CEO Oren Nissim sold his previous company, mobile and location services company Telmap, to Intel in 2012. He co-founded Brook with the company’s chief product officer, Kit Macgillivray, a longtime strategy consultant and executive who worked with Nissim at Telmap for several years.
